Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Plasma and urinary levels of dermatan sulfate and heparan sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans.

de Ru MH, van der Tol L, van Vlies N, Bigger BW, Hollak CE, Ijlst L, Kulik W, van Lenthe H, Saif MA, Wagemans T, van der Wal WM, Wanders RJ, Wijburg FA.

J Inherit Metab Dis. 2013 Mar;36(2):247-55. doi: 10.1007/s10545-012-9538-2. Epub 2012 Sep 19.

PMID:
22991166
[PubMed - indexed for MEDLINE]
2.

Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.

Tomatsu S, Montaño AM, Oguma T, Dung VC, Oikawa H, de Carvalho TG, Gutiérrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Sakura N, Barrera L, Kida K, Kubota M, Orii T.

J Inherit Metab Dis. 2010 Apr;33(2):141-50. doi: 10.1007/s10545-009-9036-3. Epub 2010 Feb 17.

PMID:
20162367
[PubMed - indexed for MEDLINE]
3.

Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.

Tomatsu S, Montaño AM, Oguma T, Dung VC, Oikawa H, Gutiérrez ML, Yamaguchi S, Suzuki Y, Fukushi M, Barrera LA, Kida K, Kubota M, Orii T.

Mol Genet Metab. 2010 Feb;99(2):124-31. doi: 10.1016/j.ymgme.2009.10.001. Epub 2009 Oct 12.

PMID:
19932038
[PubMed - indexed for MEDLINE]
4.

Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.

de Ruijter J, de Ru MH, Wagemans T, Ijlst L, Lund AM, Orchard PJ, Schaefer GB, Wijburg FA, van Vlies N.

Mol Genet Metab. 2012 Dec;107(4):705-10. doi: 10.1016/j.ymgme.2012.09.024. Epub 2012 Sep 28.

PMID:
23084433
[PubMed - indexed for MEDLINE]
5.

Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.

Auray-Blais C, Bhérer P, Gagnon R, Young SP, Zhang HH, An Y, Clarke JT, Millington DS.

Mol Genet Metab. 2011 Jan;102(1):49-56. doi: 10.1016/j.ymgme.2010.09.003. Epub 2010 Sep 17.

PMID:
20934363
[PubMed - indexed for MEDLINE]
6.

Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients.

Coppa GV, Buzzega D, Zampini L, Maccari F, Galeazzi T, Pederzoli F, Gabrielli O, Volpi N.

Glycobiology. 2010 Oct;20(10):1259-73. doi: 10.1093/glycob/cwq088. Epub 2010 Jun 9.

PMID:
20538645
[PubMed - indexed for MEDLINE]
Free Article
7.

Heparan sulfate derived disaccharides in plasma and total urinary excretion of glycosaminoglycans correlate with disease severity in Sanfilippo disease.

de Ruijter J, Ijlst L, Kulik W, van Lenthe H, Wagemans T, van Vlies N, Wijburg FA.

J Inherit Metab Dis. 2013 Mar;36(2):271-9. doi: 10.1007/s10545-012-9535-5. Epub 2012 Sep 12.

PMID:
22968582
[PubMed - indexed for MEDLINE]
8.

Newborn screening and diagnosis of mucopolysaccharidoses.

Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M, Kida K, Shibata Y, Futatsumori H, Montaño AM, Mason RW, Yamaguchi S, Suzuki Y, Orii T.

Mol Genet Metab. 2013 Sep-Oct;110(1-2):42-53. doi: 10.1016/j.ymgme.2013.06.007. Epub 2013 Jun 21. Review.

PMID:
23860310
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.

Langford-Smith K, Arasaradnam M, Wraith JE, Wynn R, Bigger BW.

Mol Genet Metab. 2010 Mar;99(3):269-74. doi: 10.1016/j.ymgme.2009.10.175. Epub 2009 Oct 23.

PMID:
19926322
[PubMed - indexed for MEDLINE]
10.

Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses.

Volpi N, Maccari F, Galeotti F, Zampini L, Santoro L, Padella L, Galeazzi T, Gabrielli O, Coppa GV.

J Pharm Biomed Anal. 2013 Nov;85:40-5. doi: 10.1016/j.jpba.2013.06.026. Epub 2013 Jul 4.

PMID:
23872470
[PubMed - indexed for MEDLINE]
11.

Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients.

Clarke LA, Hemmelgarn H, Colobong K, Thomas A, Stockler S, Casey R, Chan A, Fernoff P, Mitchell J.

J Inherit Metab Dis. 2012 Mar;35(2):355-62. doi: 10.1007/s10545-011-9369-6. Epub 2011 Jul 6.

PMID:
21732093
[PubMed - indexed for MEDLINE]
12.

Isolation, identification, and quantitation of urinary glycosaminoglycans.

Lee EY, Kim SH, Whang SK, Hwang KY, Yang JO, Hong SY.

Am J Nephrol. 2003 May-Jun;23(3):152-7. Epub 2003 Mar 19.

PMID:
12646785
[PubMed - indexed for MEDLINE]
13.

Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.

Erkurt B, Ilker Y, Budak Y, Ozveren B, Türkeri L, Akdas A.

J Endourol. 1999 Oct;13(8):553-7.

PMID:
10597124
[PubMed - indexed for MEDLINE]
14.

A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.

Chuang CK, Lin HY, Wang TJ, Tsai CC, Liu HL, Lin SP.

Orphanet J Rare Dis. 2014 Sep 2;9(1):135. [Epub ahead of print]

PMID:
25178307
[PubMed - as supplied by publisher]
Free Article
15.
16.

Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.

Gallegos-Arreola MP, González-Noriega A, Zúñiga-González GM, Flores-Martínez SE, Morán Moguel MC, Figuera LE, Sánchez-Corona J.

Arch Med Res. 1997 Spring;28(1):91-4.

PMID:
9078594
[PubMed - indexed for MEDLINE]
17.

Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases.

Langford-Smith KJ, Mercer J, Petty J, Tylee K, Church H, Roberts J, Moss G, Jones S, Wynn R, Wraith JE, Bigger BW.

J Inherit Metab Dis. 2011 Apr;34(2):499-508. doi: 10.1007/s10545-010-9254-8. Epub 2010 Dec 18.

PMID:
21170681
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.

Zhang H, Young SP, Millington DS.

Curr Protoc Hum Genet. 2013;Chapter 17:Unit 17.12. doi: 10.1002/0471142905.hg1712s76.

PMID:
23315926
[PubMed - indexed for MEDLINE]
19.

Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II patient.

Volpi N, Zampini L, Maccari F, Santoro L, Galeotti F, Galeazzi T, Gabrielli O, Coppa GV.

Glycoconj J. 2013 Oct;30(7):727-32. doi: 10.1007/s10719-013-9471-0. Epub 2013 Mar 20.

PMID:
23512580
[PubMed - indexed for MEDLINE]
20.

Alterations in serum glycosaminoglycan profiles in Graves' patients.

Komosińska-Vassev K, Winsz-Szczotka K, Olczyk K, Koźma EM.

Clin Chem Lab Med. 2006;44(5):582-8.

PMID:
16681428
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk